This announcement is a separate document:
MIRA Pharmaceuticals | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Brian McNulty, Individually and as Trustee of the Bay Shore Trust(31.01%),Bay Shore Trust(26.94%)
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.